Back to all studies
RecruitingNCT07396272

A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression

This recruiting study focuses on depression and currently lists sites or participation links in Sweden.

DepressionOtherFrom 18 Years to 75 Years
In plain English

Key information made simple

This study exists to understand how the medication Add-on holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Add-on can give earlier or clearer feedback during care. For people living with Depression, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Adult Psychiatry in Lund. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include pregnancy or breastfeeding and safety concerns that need urgent care first. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT07396272. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in Sweden.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com